BioCentury
ARTICLE | Financial News

Quan doubles down with new $250M fund

September 5, 2019 10:26 PM UTC

With the close of a second fund bringing its managed capital to around $400 million, Quan Capital plans to stick to its strategy of investing in innovative therapeutics, according to Managing Director Marietta Wu.

Wu told BioCentury the firm closed Quan Fund II at $250 million with backing from LPs that come from “most of the major categories of institutional investors” and plans to invest in both early and late stage companies...

BCIQ Company Profiles

Quan Capital